Ono Pharmaceutical Korea will conduct active marketing this year

Published: 2015-02-16 13:48:31

Updated: 2015-02-16 13:48:31

It is known that Ono Pharmaceutical Korea will take its first huge step in the Korean market.

The company’s marketing in Korea will be preceded through a partnership with BMS Korea.

This is because BMS and Ono Pharmaceutical Korea have made the partnership the last July to develop and commercialize ‘Opdivo’, the BMS’s CTLA-4 immune checkpoint blockade ‘Yervoy’, the KIR (Killer-cell immunoglob...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.